Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer

by Jedrzej J. Jaworski, Robert D. Morgan, Shivan Sivakumar
Published 2020-12-01

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer

by Robert D Morgan, Andrew R Clamp, Jurjees Hasan, Gordon C Jayson, Sofia Stamatopoulou, Nerissa Mescallado, Geoff Saunders, Richard Welch, Claire Mitchell
Published 2019-04-01

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes

by Bethany M. Barnes, Louisa Nelson, Anthony Tighe, George J. Burghel, I-Hsuan Lin, Sudha Desai, Joanne C. McGrail, Robert D. Morgan, Stephen S. Taylor
Published 2021-09-01

Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers

by Anne Marie Sowerbutts, Simon Lal, Jana Sremanakova, Andrew R. Clamp, Gordon C. Jayson, Antje Teubner, Lisa Hardy, Chris Todd, Anne-Marie Raftery, Eileen Sutton, Robert D. Morgan, Alexander J. Vickers, Sorrel Burden
Published 2019-12-01

Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian Cancer

by Robert D. Morgan, George J. Burghel, Helene Schlecht, Andrew R. Clamp, Jurjees Hasan, Claire L. Mitchell, Zena Salih, Joseph Shaw, Sudha Desai, Gordon C. Jayson, Emma R. Woodward, D. Gareth R. Evans
Published 2023-12-01

c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial

by Robert D. Morgan, Cristina Ferreras, Isabel Peset, Egle Avizienyte, Andrew G. Renehan, Richard J. Edmondson, Alexander D. Murphy, Shibani Nicum, Thomas Van Brussel, Andrew R. Clamp, Diether Lambrechts, Cong Zhou, Gordon C. Jayson
Published 2022-02-01

Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models

by Camilla Coulson-Gilmer, Robert D. Morgan, Louisa Nelson, Bethany M. Barnes, Anthony Tighe, René Wardenaar, Diana C. J. Spierings, Helene Schlecht, George J. Burghel, Floris Foijer, Sudha Desai, Joanne C. McGrail, Stephen S. Taylor
Published 2021-10-01

Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

by Robert D. Morgan, George J. Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Andrew R. Clamp, Jurjees Hasan, Claire L. Mitchell, Zena Salih, Emma R. Woodward, Fiona Lalloo, Emma J. Crosbie, Richard J. Edmondson, Helene Schlecht, Gordon C. Jayson, D. Gareth R. Evans
Published 2023-01-01

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study

by Reem D. Mahmood, Danielle Shaw, Tine Descamps, Cong Zhou, Robert D. Morgan, Saifee Mullamitha, Mark Saunders, Nerissa Mescallado, Alison Backen, Karen Morris, Ross A. Little, Susan Cheung, Yvonne Watson, James P. B. O’Connor, Alan Jackson, Geoff J. M. Parker, Caroline Dive, Gordon C. Jayson
Published 2021-04-01

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

by Chloe A. Logue, MBChB, MRes, Julia Pugh, BNurs (hons), MSc, PGDip, Philip Foden, BSc, MSc, Reem D. Mahmood, MBChB, MRCP, Robert D. Morgan, MBBS, Claire Mitchell, MBBS, MRCP, PhD, Jurjees Hasan, MSc, MD, FRCP, Andrew R. Clamp, MA, BMBCh, PhD, Gordon C. Jayson, PhD, FRCP
Published 2022-02-01

A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity

by Louisa Nelson, Anthony Tighe, Anya Golder, Samantha Littler, Bjorn Bakker, Daniela Moralli, Syed Murtuza Baker, Ian J. Donaldson, Diana C. J. Spierings, René Wardenaar, Bethanie Neale, George J. Burghel, Brett Winter-Roach, Richard Edmondson, Andrew R. Clamp, Gordon C. Jayson, Sudha Desai, Catherine M. Green, Andy Hayes, Floris Foijer, Robert D. Morgan, Stephen S. Taylor
Published 2020-02-01